Takeda Pharmaceutical's revenue in Asia FY 2018-2022
In fiscal year 2022, the revenue of Takeda Pharmaceutical Co., Ltd. generated in Asia accounted for approximately 225 billion Japanese yen, marking the highest revenue over a five-year period. In contrast, the company's revenue in Asian countries in fiscal year 2018 amounted to around 105.4 billion yen.